Some people with early-stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, a new study shows.
Immunotherapy drug capable of eliminating tumors in some early-stage cancers: Study
You May Also Like
More From Author
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
